Vaccinating the Masses During a Pandemic: Learning in Real Time for Tomorrow.

In the article, the author discusses how the mass vaccination process to vaccinate Americans to control the coronavirus pandemic in the U.S. can serve as a lesson for proper response to public health emergencies in the future. Also cited are the aspects of the vaccination programs that promote bette...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Public Health Vol. 113; no. 8; pp. 836 - 839
Autor principal: Brandt, Heather M.
Formato: Artículo
Publicado: American Public Health Association Aug2023
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=164724005&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 164724005
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00900036
        APH
      jtl: American Journal of Public Health
      issn: 00900036
      maglogo: N
    pubinfo:
      dt: Aug2023
      vid: 113
      iid: 8
      pid: 44
      pub: American Public Health Association
    artinfo:
      ui:
        164724005
        10.2105/AJPH.2023.307358
      ppf: 836
      ppct: 3
      formats:
      tig:
        atl: Vaccinating the Masses During a Pandemic: Learning in Real Time for Tomorrow.
      aug:
        au: Brandt, Heather M.
        affil: Heather M. Brandt is the director of the HPV Cancer Prevention Program and full member in the Department of Epidemiology and Cancer Control at St. Jude Children's Research Hospital, Memphis, TN.
      su:
        Evaluation of medical care
        Immunization
        Health services accessibility
        Public health
        Government programs
        Health equity
        COVID-19 pandemic
        COVID-19
        COVID-19 vaccines
        Drug design
        RNA
        Drug administration
        Infection control
        Medical care use
        Drug development
        Risk management in business
      sug:
        subj:
          Evaluation of medical care
          Immunization
          Health services accessibility
          Public health
          Government programs
          Health equity
          COVID-19 pandemic
          Health and Welfare Funds
          Research and development in the physical, engineering and life sciences
          Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
          COVID-19
          COVID-19 vaccines
          Drug design
          RNA
          Drug administration
          Infection control
          Medical care use
          Drug development
          Risk management in business
      ab: In the article, the author discusses how the mass vaccination process to vaccinate Americans to control the coronavirus pandemic in the U.S. can serve as a lesson for proper response to public health emergencies in the future. Also cited are the aspects of the vaccination programs that promote better preparation including leveraging partnerships, tackling health equity, and prioritizing risk management and control, as well as the importance of supply and administration in effective response.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N